New York Cancer and Blood Specialists

East Setauket, New York 11733

0 studies enrolling now · 4 studies all time

What they study most

Advanced Breast Cancer, Breast Cancer, Metastatic Breast Cancer

Studies at this site

• Palbociclib in Real World Practice — Completed
• Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC — Stopped early
• Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBC — Stopped early
• Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Triple-Negative MBC and Tesetaxel Monotherapy in Patients With HER2-Negative MBC — Stopped early